0001564590-22-016437.txt : 20220428 0001564590-22-016437.hdr.sgml : 20220428 20220428160657 ACCESSION NUMBER: 0001564590-22-016437 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220422 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant FILED AS OF DATE: 20220428 DATE AS OF CHANGE: 20220428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DermTech, Inc. CENTRAL INDEX KEY: 0001651944 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 842870849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38118 FILM NUMBER: 22866512 BUSINESS ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-450-4222 MAIL ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD STREET 2: SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Constellation Alpha Capital Corp. DATE OF NAME CHANGE: 20150827 8-K 1 dmtk-8k_20220422.htm 8-K dmtk-8k_20220422.htm
false 0001651944 0001651944 2022-04-22 2022-04-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549  

 

FORM 8-K 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 22, 2022  

 

DERMTECH, INC.

(Exact name of registrant as specified in its charter)  

 

 

 

 

 

 

Delaware

 

001-38118

 

84-2870849

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

11099 N. Torrey Pines Road, Suite 100

La Jolla, CA 92037

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code (858) 450-4222 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

DMTK

The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

 


 

 

Item 1.01 Entry into a Material Definitive Agreement.  

As previously disclosed, on July 1, 2021, DermTech, Inc., or the Company, entered into an Office Lease, or the Original Lease Agreement, dated July 1, 2021, with Kilroy Realty, L.P., or the Landlord, with respect to an aggregate of 95,997 rentable square feet, consisting of the entire building located at 12340 El Camino Real, San Diego, California 92130, or the Premises. On April 22, 2022, the Company entered into the First Amendment to Office Lease, or the First Amendment, and the Second Amendment to Office Lease, of the Second Amendment.

The Original Lease Agreement entitled the Company to an aggregate allowance of $11,999,625.00 to make certain improvements, or the Improvements, to the Premises, referred to as the Improvement Allowance, as well as a one-time increase in the Improvement Allowance, or the Additional Improvement Allowance, in an amount not to exceed $2,399,925.00 (i.e., $25.00 per rentable square foot of the Premises), for the costs relating to the initial design and construction of the Improvements.  Pursuant to the First Amendment, the Company elected to utilize the entirety of the Additional Improvement Allowance. In accordance with the First Amendment, the Company will pay an increased monthly base rent in order to repay the Additional Improvement Allowance to Landlord, as set forth on Schedule 1 to the First Amendment, which replaces the payment schedule contained in the Original Lease Agreement, in its entirety. The payment schedule is structured in four phases. Phase I commenced on September 1, 2021 and Phase II commenced on March 10, 2022.

 

Pursuant to the Second Amendment, the Company elected to expand the Premises to include 14,085 rentable and usable square feet comprising the executive parking level, or the Expansion Premises. The Landlord will tender possession of the Expansion Premises following substantial completion of Improvements, pursuant to the agreed upon Work Letter set forth in Exhibit B of the Second Amendment.

 

The Second Amendment is expressly conditioned upon the receipt of all required approvals and permits from the applicable governmental authorities with respect to the conversion of the Expansion Premises from a parking area into occupiable space, or the Condition Subsequent. The Landlord will not be liable to the Company for the Landlord’s inability or failure to cause all or any portion of the Condition Subsequent to be satisfied. The Second Amendment will not take effect unless and until the Condition Subsequent is satisfied, and in the event the Condition Subsequent is not satisfied within nine months following the effective date of the Second Amendment, then the Second Amendment will be null and void.

 

As the Landlord tenders possession of the Expansion Premises upon satisfaction of the Condition Subsequent, the Company will be obligated to pay the Landlord increased monthly installments of base rent for the Expansion Premises, as set forth in Section 4.2 of the Second Amendment.

 

The Second Amendment also acknowledges that the Company previously delivered to the Landlord a security deposit in the amount of $3,023,905.50, in the form of a letter of credit, or the Existing L-C, in accordance with the Original Lease Agreement. Pursuant to the Second Amendment, the Company will deliver to the Landlord a new letter of credit, or the New L-C, within 14 days following entry into the Second Amendment, in the total amount of $3,467,512.44. In connection with the New L-C, the schedule for the remaining letter of credit amount in the Original Lease Agreement will be replaced with the schedule set forth in Section 9 of the Second Amendment.

 

The foregoing summary is qualified in its entirety by reference to the full text of the First Amendment and Second Amendment, copies of which will be attached to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.  

 

The disclosures set forth above under Item 1.01 are incorporated herein by reference.

 

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DERMTECH, INC.

 

 

 

 

Date: April 28, 2022

 

 

 

By:

 

/s/ Kevin Sun

 

 

 

 

 

 

Name: Kevin Sun

 

 

 

 

 

 

Title: Chief Financial Officer

 

 

 

EX-101.SCH 2 dmtk-20220422.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 dmtk-20220422_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of 12(b) Security Security12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 4 dmtk-20220422_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information
Apr. 22, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 22, 2022
Entity Registrant Name DERMTECH, INC.
Entity Central Index Key 0001651944
Entity Emerging Growth Company false
Entity File Number 001-38118
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 84-2870849
Entity Address, Address Line One 11099 N. Torrey Pines Road
Entity Address, Address Line Two Suite 100
Entity Address, City or Town La Jolla
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92037
City Area Code 858
Local Phone Number 450-4222
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol DMTK
Security Exchange Name NASDAQ
XML 6 dmtk-8k_20220422_htm.xml IDEA: XBRL DOCUMENT 0001651944 2022-04-22 2022-04-22 false 0001651944 8-K 2022-04-22 DERMTECH, INC. DE 001-38118 84-2870849 11099 N. Torrey Pines Road Suite 100 La Jolla CA 92037 858 450-4222 false false false false Common Stock, par value $0.0001 per share DMTK NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports dmtk-8k_20220422.htm dmtk-20220422.xsd dmtk-20220422_lab.xml dmtk-20220422_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dmtk-8k_20220422.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "dmtk-8k_20220422.htm" ] }, "labelLink": { "local": [ "dmtk-20220422_lab.xml" ] }, "presentationLink": { "local": [ "dmtk-20220422_pre.xml" ] }, "schema": { "local": [ "dmtk-20220422.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "dmtk", "nsuri": "http://dermtech.com/20220422", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "dmtk-8k_20220422.htm", "contextRef": "C_0001651944_20220422_20220422", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "dmtk-8k_20220422.htm", "contextRef": "C_0001651944_20220422_20220422", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dermtech.com/20220422/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001564590-22-016437-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-016437-xbrl.zip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end